1. Home
  2. ESCA vs NYXH Comparison

ESCA vs NYXH Comparison

Compare ESCA & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

HOLD

Current Price

$14.82

Market Cap

199.1M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$4.00

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
NYXH
Founded
1922
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.1M
190.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ESCA
NYXH
Price
$14.82
$4.00
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
11.1K
47.8K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
4.02%
N/A
EPS Growth
30.99
N/A
EPS
0.72
N/A
Revenue
$180,541,000.00
N/A
Revenue This Year
N/A
$97.32
Revenue Next Year
$3.00
$241.74
P/E Ratio
$20.60
N/A
Revenue Growth
2.71
N/A
52 Week Low
$11.41
$4.10
52 Week High
$16.99
$11.87

Technical Indicators

Market Signals
Indicator
ESCA
NYXH
Relative Strength Index (RSI) 54.43 37.17
Support Level $13.99 N/A
Resistance Level $14.63 $4.99
Average True Range (ATR) 0.31 0.32
MACD 0.02 -0.03
Stochastic Oscillator 55.36 7.97

Price Performance

Historical Comparison
ESCA
NYXH

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: